Shanghai Pharma announces semi-annual dividend, renews related party deal

Shanghai Pharmaceuticals Holding announced a 2025 semi-annual cash dividend of 1.20 yuan (tax inclusive) per 10 shares. This distribution will be based on the total share capital of 3,708,361,809 shares as of June 30, 2025, totaling 445,003,417.08 yuan, representing 9.98% of the company's net profit for the period. The company will adjust the total dividend amount to maintain the per-share distribution if the total share capital changes before the equity distribution record date.

Concurrently, the company renewed a procurement framework agreement with related party Yong Fa Printing Co., Ltd. for pharmaceutical printing and packaging materials. The agreement, effective from January 1, 2026, to December 31, 2026, sets an annual procurement cap of 90m yuan. Yong Fa Printing, a subsidiary of the company's controlling shareholder Shanghai Industrial (Group) Co., Ltd., previously recorded actual procurement of 6,195.98m yuan in 2024 and 4,461.07m yuan for the first nine months of 2025 against a 2025 estimated amount of 9,000m yuan.

Both the profit distribution and the procurement agreement were approved by the board of directors and independent directors. The company's net profit attributable to shareholders for the first nine months of 2025 increased by 26.96% year-on-year to 5,147,064,933.11 yuan, while operating revenue grew by 2.60% to 215,072,230,363.46 yuan.